Timolol maleate 0.5% ophthalmic solution

DRUG2 trials

Sponsors

University of Waterloo, Taipei Medical University WanFang Hospital

Conditions

Epidermal Growth Factor Receptor InhibitorGlaucomaOphthalmic SolutionsParonychia

Early Phase 1

Evaluation of a New Method for Instilling Eye Drops

CompletedNCT02697318

University of WaterlooGlaucoma, Ophthalmic Solutions

Start: 2016-05-31End: 2018-01-07Updated: 2018-01-23

Unknown Phase

The Efficacy of Topical Timolol Combined With Cryotherapy in EGFR Inhibitors-induced Paronychia - a Double-blinded, Intrapatient Left-to-right Controlled Study

CompletedNCT05165082

Taipei Medical University WanFang HospitalEpidermal Growth Factor Receptor Inhibitor, Paronychia

Start: 2021-12-21End: 2023-03-21Updated: 2023-05-06